NZ222083A - Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose - Google Patents
Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcelluloseInfo
- Publication number
- NZ222083A NZ222083A NZ222083A NZ22208387A NZ222083A NZ 222083 A NZ222083 A NZ 222083A NZ 222083 A NZ222083 A NZ 222083A NZ 22208387 A NZ22208387 A NZ 22208387A NZ 222083 A NZ222083 A NZ 222083A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition according
- hydroxypropyl methylcellulose
- microcrystalline cellulose
- acetylsalicylic acid
- weight ratio
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868624213A GB8624213D0 (en) | 1986-10-09 | 1986-10-09 | Sustained release pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ222083A true NZ222083A (en) | 1991-05-28 |
Family
ID=10605478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ222083A NZ222083A (en) | 1986-10-09 | 1987-10-07 | Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose |
Country Status (24)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
| US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| EE05022B1 (et) * | 1999-03-31 | 2008-06-16 | Janssen Pharmaceutica N.V. | Eelthelatineeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis ja hüdrofiilne kontrollitud vabanemisega preparaat |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| US7820200B2 (en) * | 2004-09-09 | 2010-10-26 | Luis Estrada Flores | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
| DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
| WO1985004100A1 (en) * | 1984-03-21 | 1985-09-26 | American Home Products Corporation | Sustained release pharmaceutical capsules |
-
1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
-
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Withdrawn
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 FI FI874414A patent/FI874414L/fi not_active IP Right Cessation
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 CA CA000548872A patent/CA1332809C/en not_active Expired - Lifetime
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1058538B2 (en) | Fast disintegrating tablets | |
| JP3037757B2 (ja) | パロキセチン錠およびその製法 | |
| CA2182004C (en) | Film coated tablet of paracetamol and domperidone | |
| AU2002361198B2 (en) | 5HT4 partial agonist pharmaceutical compositions | |
| PT1351668E (pt) | Formas de dosagem farmacêutica de libertação sustida com perfis de dissolução dependentes de ph minimizado | |
| AU2002249881A1 (en) | Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles | |
| JPH03200724A (ja) | 二重作用錠剤 | |
| JPH0415208B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| TW508242B (en) | Pharmaceutical composition comprising paracetamol | |
| KR101464771B1 (ko) | 페닐에프린의 지속 방출용 약제학적 조성물 | |
| EP1112065A1 (en) | Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative | |
| NZ222083A (en) | Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose | |
| EP1392271B1 (en) | Swallow tablet comprising paracetamol | |
| AU2002317772A1 (en) | Swallow tablet comprising paracetamol | |
| JP3836893B2 (ja) | ポリカルボフィルカルシウム含有製剤 | |
| EP1763338B1 (en) | Oral sustained release formulation of tedisamil with gastric retention properties | |
| NZ207768A (en) | Sustained release tablets comprising dipyridamole | |
| WO2005065662A1 (en) | Solid dosage formulations of galantamine | |
| JPS59193815A (ja) | 錠剤の製法 | |
| JP2023163350A (ja) | チュアブル錠又は口腔内崩壊錠 | |
| WO2009063484A2 (en) | Stable pharmaceutical composition of lamotrigine | |
| HK1062896B (en) | Swallow tablet comprising paracetamol | |
| EP1713451A1 (en) | Solid dosage formulations of galanthamine | |
| HK1010687B (en) | Film coated tablet of paracetamol and domperidone |